Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090892 · ClinicalTrials.gov registry record
Effects of Soft Tissue Lengthening on Gait in Children With Spasticity
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 8
- Enrollment target
NCT04090892: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT04090892 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04090892 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This research project is being conducted to investigate changes in secondary impairments, functional mobility skills, and gait variables in children with spasticity following selective percutaneous myofascial lengthening. The research project proposed here will be the first to use instrumented three-dimensional motion analysis to investigate the effects of selective percutaneous myofascial lengthening on gait kinematics and kinetics. The objectives of the study are to: 1. Compare gait kinematics and kinetics in children and young adults with lower extremity spasticity before and after selective percutaneous myofascial lengthening to determine the effects of this procedure on functional mobility. 2. Identify changes in impairments and activity limitations following selective percutaneous myofascial lengthening . 3. Identify changes in a family or caregivers perceived quality of life after their child's selective percutaneous myofascial lengthening . The aim of this study is to identify and describe the specific changes in secondary musculoskeletal impairments, activity limitations, and gait kinematics and kinetics after a selective percutaneous myofascial lengthening procedure. Gait kinematics and kinetics includes the motion of joints and body segments, and force and power, at each lower extremity joint, respectively. The results of this study will provide preliminary information on how this form of soft tissue lengthening affects functional mobility skills in children with spasticity. The study is expected to run for two years and the primary study endpoint is when participants have completed their second post- operative data collection session.
Primary Outcome
Lower extremity joint angles at baseline before
Interventions
- PROCEDURE selective percutaneous muscle release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-05-10 |
| Est. Completion | 2017-01-31 |
What the finished NCT04090892 record still lists
NCT04090892 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which selective percutaneous muscle release is the first listed.
NCT04090892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04090892 about?
NCT04090892 is a clinical study titled "Effects of Soft Tissue Lengthening on Gait in Children With Spasticity". This research project is being conducted to investigate changes in secondary impairments, functional mobility skills, and gait variables in children with spasticity following selective percutaneous myofascial lengthening. The research project proposed here will be the first to use instrumented three...
What is the current status of trial NCT04090892?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2016-05-10. Estimated completion is 2017-01-31.
What interventions are being tested in trial NCT04090892?
The interventions under investigation include: selective percutaneous muscle release (PROCEDURE).
Who is sponsoring clinical trial NCT04090892?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI